首页> 外文期刊>Amino acids >Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity
【24h】

Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity

机译:基于小型双功能模板的非肽PAR1凝血酶受体拮抗剂的设计,合成和生物学评估:精氨酸和苯丙氨酸侧链基团是受体活性的关键

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In the present study, we report the synthesis and biological evaluation of a series of new non-peptide PAR1 mimetic receptor antagonists, based on conformational analysis of The S_(42)FLLR_(46) tethered ligand (TL) sequence of PAR1. These compounds incorporate the key pharmacophore groups in the TL sequence, guanidyl, amino and phenyl, which are essential for triggering receptor activity. Compounds 5 and 15 (50-100 μM) inhibited both TFLLR-amide (10 μM) and thrombin-med-iated (0.5 and 1 U/ml; 5 and 10 μM) calcium signaling in a cultured human HEK cell assay.
机译:在本研究中,我们基于对PAR1的S_(42)FLLR_(46)拴系配体(TL)序列的构象分析,报告了一系列新型非肽PAR1模拟受体拮抗剂的合成和生物学评估。这些化合物在TL序列中结合了关键的药效基团,胍基,氨基和苯基,这对于触发受体活性至关重要。在培养的人HEK细胞测定中,化合物5和15(50-100μM)抑制TFLLR-酰胺(10μM)和凝血酶介导的(0.5和1 U / ml; 5和10μM)钙信号传导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号